Study of the Effect of Peripheral Somatosensory Stimulation on the Functionality of Patients With Cerebral Palsy and Reduced Mobility

Launched by FACULTAT DE CIENCIES DE LA SALUT UNIVERSITAT RAMON LLULL · Apr 22, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help adults with cerebral palsy (CP) improve their movement and daily activities. Cerebral palsy is a condition that affects muscle control and posture, often leading to challenges in mobility. The study aims to enhance motor function through a technique called peripheral somatosensory stimulation, which involves using sensory feedback to stimulate the lower limbs as part of an intensive rehabilitation program. The goal is to help participants gain more independence in their movements and participate more actively in everyday life.

To participate in this study, individuals must be adults aged 18 to 50 who have been diagnosed with cerebral palsy and have some level of reduced mobility. They should also be able to take part in assessments with the help of a clinical team and understand the study guidelines. However, those with severe cognitive impairments or other serious medical conditions that could affect their participation will not be eligible. Participants can expect to engage in rehabilitation sessions that focus on improving their movement abilities, all while being supported by healthcare professionals.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria
• • Adults with a medical diagnosis of cerebral palsy
• • Age: 18-50 years
• • Reduced mobility classified as levels I, II, or III according to the GMFCS
• • Ability to participate in functional assessments with the support of the clinical team
• • Ability to understand informed consent or have a legal representative who can provide consent on their behalf
• • Exclusion Criteria
• • Patients with cerebral palsy who have severe cognitive impairments that hinder understanding of instructions or participation in assessments
• • Adults with cerebral palsy who present with medical conditions that may interfere with the intervention, such as severe cardiovascular disease or major neurological disorders
• • Individuals with cerebral palsy who are participating in another intervention study during the same period